Russell Olsen, senior vice president of operations and administration for Straumann USA, tells GlobeSt.com that Straumann, which has an office in the city of approximately 25,000 sf, is looking to build a 150,000- to 200,000-sf facility. The space would be a combination of manufacturing and office space and would direct the company's distribution, manufacturing and marketing businesses in the US.
Olsen tells GlobeSt.com that the company was considering settling in a number of states including New York, New Jersey, North Carolina and Pennsylvania. Olsen says the company settled on Massachusetts because of the quality of the workforce, which has a technical skill set in manufacturing as well as the availability of health care professionals. He notes that the state's tax incentive program was also very competitive compared to other areas and figured largely in the company's decision. Russell could not be specific as to the tax incentives because it varies depending upon the location and the number of jobs created.
A spokesperson for Romney tells GlobeSt.com that the governor was very involved in bringing Straumann to the state. Romney, and a team of economic development representatives, met with the company this past May. The Straumann deal comes on the heels of the governor's initiative to hasten the pace at which biotech companies can expand their businesses in the state.
Olsen says that the company intends to identify a site within the next 60 days. "We are open to any location," he says. "We are looking at existing facilities all over the state."
© Touchpoint Markets, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to asset-and-logo-licensing@alm.com. For more inforrmation visit Asset & Logo Licensing.
